Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However, frequent irregular...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lipid management and cardiovascular risk assessment: Physician perspectives from seven countries across five WHORegions - insights from the INTERASPIRE study.

American journal of preventive cardiology·2026
Same author

Predicting lifetime cardiovascular risk and benefits of preventive treatment in patients with established atherosclerotic cardiovascular disease: the SMART-REACH2 model.

European heart journal·2026
Same author

Plasma cell-free transcriptome profiling in blood plasma from chronic liver disease patients.

Scientific data·2026
Same author

Female sex is independently associated with poor health-related quality of life in patients with coronary heart disease across 14 countries: the INTERASPIRE study.

International journal of cardiology·2026
Same author

Chronic Kidney Disease Screening in Patients With Coronary Heart Disease: The Multinational INTERASPIRE Study.

Journal of the American College of Cardiology·2026
Same author

Prevalence and characteristics of patients with coronary heart disease and blood pressure below target: the INTERASPIRE study.

Heart (British Cardiac Society)·2026

Related Experiment Video

Updated: May 22, 2026

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

Cardiovascular risk age: concepts and practicalities.

Marie Therese Cooney1, Erkki Vartiainen, Tiina Laatikainen

  • 1Department of Cardiology, Adelaide Meath Hospital, Dublin, Ireland.

Heart (British Cardiac Society)
|May 26, 2012
PubMed
Summary
This summary is machine-generated.

Risk age is a novel way to communicate cardiovascular disease (CVD) risk, especially for younger individuals. This method helps patients understand their risk level, potentially encouraging healthier lifestyle choices.

More Related Videos

Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression
13:07

Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression

Published on: January 15, 2022

Related Experiment Videos

Last Updated: May 22, 2026

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression
13:07

Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression

Published on: January 15, 2022

Area of Science:

  • Cardiovascular disease risk assessment
  • Preventive cardiology
  • Health communication

Background:

  • Cardiovascular disease (CVD) risk increases with age and risk factors.
  • A younger individual with multiple risk factors can have a similar risk profile to an older individual with fewer risk factors.
  • The concept of 'risk age' aims to provide a more intuitive understanding of an individual's CVD risk.

Purpose of the Study:

  • To derive a generic equation for calculating risk age.
  • To construct risk age charts for practical application.
  • To investigate if risk age remains consistent across different cardiovascular disease (CVD) endpoints.

Main Methods:

  • A generic 10-year CVD risk formula was equated to a formula with ideal risk factors to solve for 'risk age' (x).
  • Risk ages were calculated for participants in the FINRISK study using both fatal CVD events and total CVD events (fatal and non-fatal).
  • The correlation between risk ages derived from different endpoints was analyzed.

Main Results:

  • A generic equation for risk age was successfully derived.
  • A specific table for Systematic COronary Risk Evaluation (SCORE) risk ages was created due to age being a baseline factor in that system.
  • Risk age demonstrated consistency across different CVD endpoints (fatal vs. total events).
  • The derived risk age equation is independent of baseline survival, negating the need for recalibration.

Conclusions:

  • Risk age offers an intuitive communication tool for CVD risk, particularly beneficial for younger patients.
  • Utilizing risk age may encourage younger individuals to adopt healthier lifestyles.
  • Clinical decisions regarding CVD prevention should still primarily rely on absolute risk assessment as per current guidelines.